ACRS Competitors & Alternatives
Compare Aclaris Therapeutics Inc with similar stocks in the same industry
Biotechnology
ACRS
Main Stock$4.96
Tradestie Score
56
Market Cap
$202.58M
Revenue Growth
0.4%
Analyst Upside
+101.6%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TYRA
Tyra Biosciences, Inc. Common Stock
|
$30.72
|
$715.25M | - | 56 | Compare |
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
|
$704.73M | - | 59 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$119.04
|
$699.30M | - | 60 | Compare |
|
GYRE
Gyre Therapeutics, Inc. Common Stock
|
$6.16
|
$688.47M | - | 56 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 57 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$11.72
|
$665.30M | - | 61 | Compare |
|
ANL
ANL
|
$10.70
|
$650.42M | - | 53 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$15.30
|
$626.91M | - | 54 | Compare |
|
SVRA
Savara Inc.
|
$5.82
|
$611.84M | - | 62 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 57 | Compare |
More ACRS Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry